No Data
No Data
Jiangsu Hengrui Pharmaceuticals sold innovative molecules to Merck in Germany, successfully completing two external licensing deals within half a month.
① Jiangsu Hengrui Pharmaceuticals accelerates its international expansion, achieving two external licensing agreements for Innovative Drugs within half a month; ② In response to tariffs, Jiangsu Hengrui Pharmaceuticals stated that it will continue to closely monitor changes in the international environment and respond flexibly to the complex and changing external conditions, ensuring the company's long-term stability.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Alibaba Cloud is racing wildly in the automotive industry.
Create disruption.
[Data Analysis] Institutions are intensely competing over Luxshare Precision Industry, with a significant decrease in the activity level of Algo funds.
① The limit-down Luxshare Precision Industry was bought by four institutions for 0.593 billion, while it was sold by four institutions for 0.443 billion. In addition, multiple Consumer Electronics and high export proportion Concept stocks were sold by institutions. ② The activity of Algo funds decreased today, with a clear reduction in the amount and number of stocks being bought and sold.
Little K broadcasts the morning news | Contemporary Amperex Technology denies that the accident vehicle of Xiaomi is equipped with its Battery. OpenAI releases AI Agent evaluation benchmarks.
① Four departments: Shanghai and nine other cities included in the first batch of pilot zones for large-scale applications of vehicle-network interaction; ② Hubei: Focused support for the cultivation of trillion-level clusters in fields such as Wuhan Asia Vets connected Autos; ③ ShanDong: Plans to issue three action plans integrating culture and Technology, Brain-computer Interface, and quantum Technology.
New executives appointed! Jiangsu Hengrui Pharmaceuticals appoints a new president, aiming to strengthen internationalization?|Quick announcement summary
① Feng Ji, who has worked for AstraZeneca for many years, has officially been appointed as the President and Chief Operating Officer of Jiangsu Hengrui Pharmaceuticals. ② According to industry insiders, the current executive team at Hengrui remains stable, with no significant changes in the roles of other major executives. ③ Industry insiders believe that Jiangsu Hengrui Pharmaceuticals values Feng Ji's experience in multinational pharmaceutical companies.
MoneyFreedomFighter : I think you can try to ask the issuer to increase the number of unit ..they increase the number of unit depend on the demand every year.